Back
RxSight Quote, Financials, Valuation and Earnings
Sponsored
RXST
Sponsored
Hint at where the next big move in the market will be this month
Spot the next big move with this free book from a hedge fund manager
Sell
30
RXST
RxSight
Last Price:
53.42
Seasonality Move:
-0.72%
7 Day Trial
ALL ACCESS PASS
$
7
32,481% Growth? Meet Mode Mobile's "EarnPhone"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.RxSight Price Quote
$53.42
-0.74 (-1.37%)
(Updated: September 19, 2024 at 6:55 PM ET)
RxSight Key Stats
Sell
30
RxSight (RXST)
is a Sell
Day range:
$54.06 - $56.42
52-week range:
$20.66 - $66.54
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
17.27
P/B ratio:
7.81%
Volume:
508.3K
Avg. volume:
433.9K
1-year change:
91.85%
Market cap:
$2.1B
Revenue:
$89.1M
EPS:
$-1.01
How Much Does RxSight Make?
Is RxSight Growing As A Company?
RxSight Stock Price Performance
What Is RxSight 52-Week High & Low?
RxSight Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy RxSight?
Is RxSight Cash Flow Positive?
RxSight Return On Invested Capital
RxSight Earnings Date & Stock Price
-
What Is RxSight's Stock Price Today?
A single share of RXST can be purchased today for 54.16 -
What Is RxSight’s Stock Symbol?
RxSight trades on the nasdaq under the ticker symbol: RXST -
When Is RxSight’s Next Earnings Date?
The next quarterly earnings date for RxSight is scheduled on November 8, 2024 -
When Is RXST's next ex-dividend date?
RxSight's next ex-dividend date is September 20, 2024 -
How To Buy RxSight Stock?
You can buy RxSight shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
RxSight Competitors
RxSight Dividend Yield
-
What Is RXST Dividend Yield?
RxSight’s dividend yield currently is 0% -
What Is RxSight’s Payout Ratio?
RxSight’s payout ratio is 0% -
When Did RxSight Last Pay A Dividend?
The latest dividend pay date is September 20, 2024 -
What Is RxSight’s Dividend Per Share?
RxSight pays a dividend of $0.00 per share
RxSight Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 100.64% |
Revenue: | 67.65% | 8.68% |
Analyst Recommendations
Buy Recommendations: | 5 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 64.50 |
Upside from Last Price: | 19.09% |